Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
56.33
+1.42 (2.59%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $3.29 billion. The enterprise value is $2.51 billion.

Market Cap 3.29B
Enterprise Value 2.51B

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date Nov 11, 2024
Ex-Dividend Date n/a

Share Statistics

APGE has 58.49 million shares outstanding. The number of shares has increased by 1,022.94% in one year.

Shares Outstanding 58.49M
Shares Change (YoY) +1,022.94%
Shares Change (QoQ) +12.60%
Owned by Insiders (%) 2.06%
Owned by Institutions (%) 78.92%
Float 29.05M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.26
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 27.70, with a Debt / Equity ratio of 0.01.

Current Ratio 27.70
Quick Ratio 27.47
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -26.73% and return on invested capital (ROIC) is -20.17%.

Return on Equity (ROE) -26.73%
Return on Assets (ROA) -19.30%
Return on Capital (ROIC) -20.17%
Revenue Per Employee n/a
Profits Per Employee -$1.30M
Employee Count 91
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +257.42% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +257.42%
50-Day Moving Average 52.89
200-Day Moving Average 48.35
Relative Strength Index (RSI) 56.79
Average Volume (20 Days) 332,728

Short Selling Information

The latest short interest is 6.87 million, so 11.74% of the outstanding shares have been sold short.

Short Interest 6.87M
Short Previous Month 7.23M
Short % of Shares Out 11.74%
Short % of Float 23.63%
Short Ratio (days to cover) 14.72

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -143.76M
Pretax Income -103.55M
Net Income -118.49M
EBITDA n/a
EBIT -143.76M
Earnings Per Share (EPS) -$2.41
Full Income Statement

Balance Sheet

The company has $676.23 million in cash and $4.08 million in debt, giving a net cash position of $785.54 million or $13.43 per share.

Cash & Cash Equivalents 676.23M
Total Debt 4.08M
Net Cash 785.54M
Net Cash Per Share $13.43
Equity (Book Value) 773.64M
Book Value Per Share 13.23
Working Capital 657.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$110.57 million and capital expenditures -$569,000, giving a free cash flow of -$111.14 million.

Operating Cash Flow -110.57M
Capital Expenditures -569,000
Free Cash Flow -111.14M
FCF Per Share -$1.90
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,022.94%
Shareholder Yield -1,022.94%
Earnings Yield -3.60%
FCF Yield -3.37%

Analyst Forecast

The average price target for APGE is $75.20, which is 33.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target $75.20
Price Target Difference 33.50%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 1.91%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2